Priority Areas
Based on our unique drug discovery “Compound-Orient” approach finding diseases against
which the properties of compounds are most potentially effective,
we have identified the therapeutic areas with high medical needs as our priority areas of research
to develop new drugs that will provide new treatment options with innovation to the frontline of healthcare.
For this, we will strengthen and enhance research and drug discovery alliance with world-leading universities,
research institutes, and biopharmaceutical companies in specific research areas.
We will also drive forward activities in areas with great medical needs,
by in-licensing innovative compounds and acquiring novel technologies.
Oncology
As a pioneer in cancer immunotherapy, Ono Pharmaceutical Co.,Ltd. takes advantage of its experience, technology and knowhow, nurtured through R&D of the immune checkpoint inhibitor, toward discovering innovative anticancer drugs.
Immunology & Inflammation
Building on decades of continuous research experience and accumulated expertise in immunology that contributed to the discovery of Opdivo, Ono Pharmaceutical Co., Ltd. has established a Research Center for Immunology. At this center, drug discovery efforts focus on immune mediated inflammatory diseases with significant unmet medical needs, leveraging optimal modalities tailored to each therapeutic target.
Neurology
In the Neurology area, Ono Pharmaceutical Co.,Ltd. is prioritizing its research in biology of Glial cells, which maintain and support the environment necessary for survival and functional expression of neurons. Drug discovery based on human evidence would bring patients disease-modifying therapies, as well as symptomatic treatments for neurodegenerative disease, mental illness or chronic pain.
